CAS: 17652-24-3

Prednisolone 17,21-diacetate is a glucocorticoid derivative, which is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties. It is an ester derivative of prednisolone, sourced synthetically through chemical modification to enhance its pharmacokinetic profile. This compound acts by binding to glucocorticoid receptors, influencing gene expression to regulate the biosynthesis of anti-inflammatory proteins and inhibit the production of pro-inflammatory cytokines. This modulation of the immune response significantly reduces inflammation and allergic reactions. In scientific and medical applications, Prednisolone 17,21-diacetate is employed primarily for its anti-inflammatory effects. It is utilized in research settings to study inflammatory pathways and immune response mechanisms. Clinically, it can be considered for various inflammatory and autoimmune conditions, including arthritis, allergic reactions, and asthma, among others. Its role in modulating immune responses also makes it an important tool in transplant medicine and other scenarios where immune suppression is desirable. The utility of this compound extends to exploring novel therapeutic strategies in both preclinical and clinical research settings.